Novo Nordisk is gradually ending production of human insulin pens, the drugmaker told Reuters, as it spends billions to ramp ...

Novo Nordisk is ceasing production of human insulin pens, focusing on newer obesity and diabetes injections. This shift has ...

Novo Nordisk (NVO) reportedly plans to phase out production of human insulin pens while it ramps up production of other injected diabetes medications such as Ozempic. Read more.

Millions in South Africa face rising diabetes treatment costs and limited access to insulin pens, sparking protests.

In the world of health, Novo Nordisk stops insulin pen production, Trump's potential health appointments draw attention, and ...

Merck has signed a licensing agreement worth up to $3.3 billion with Shanghai-based LaNova Medicines to develop, make and ...

In Uganda, especially in rural Uganda and the elderly populace, the diabetes epidemic presents daunting hurdles ...

Diabetes management has come a long way, with treatment options now as varied as they are effective. No longer limited to ...

Belly fat, a concern for both appearance and health, can be tackled through sustainable lifestyle changes. Prioritizing a ...

On World Diabetes Day, it's worth taking a look back at the last 10.5 months in the diabetes technology space.

Thursday is World Diabetes Day. Diabetes affects 40 million Americans and for most, the best form of treatment includes ...

Eli Lilly's tirzepatide cut the risk of developing type 2 diabetes for people with pre-diabetes by 94%, according to new ...